Cite
Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells.
MLA
Zhang, Luyao, et al. “Lipopolysaccharide Modification Enhances the Inhibitory Effect of Clodronate Liposomes on Hepatic Fibrosis by Depletion of Macrophages and Hepatic Stellate Cells.” Chemico-Biological Interactions, vol. 395, May 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cbi.2024.111015.
APA
Zhang, L., Tao, M., Zhang, H., Zhang, S., Hou, X., Zong, C., Sun, G., Feng, S., Yan, H., Lu, Y., Yang, X., Wei, L., & Zhang, L. (2024). Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells. Chemico-Biological Interactions, 395, N.PAG. https://doi.org/10.1016/j.cbi.2024.111015
Chicago
Zhang, Luyao, Min Tao, Hengyan Zhang, Shichao Zhang, Xiaojuan Hou, Chen Zong, Gangqi Sun, et al. 2024. “Lipopolysaccharide Modification Enhances the Inhibitory Effect of Clodronate Liposomes on Hepatic Fibrosis by Depletion of Macrophages and Hepatic Stellate Cells.” Chemico-Biological Interactions 395 (May): N.PAG. doi:10.1016/j.cbi.2024.111015.